The latest closing stock price for Moleculin Biotech as of February 20, 2025 is 1.40.
An investor who bought $1,000 worth of Moleculin Biotech stock at the IPO in 2016 would have $-998 today, roughly -1 times their original investment - a -50.02% compound annual growth rate over 9 years.
The all-time high Moleculin Biotech stock closing price was 801.00 on June 03, 2016.
The Moleculin Biotech 52-week high stock price is 10.34, which is 638.6% above the current share price.
The Moleculin Biotech 52-week low stock price is 0.40, which is 71.4% below the current share price.
The average Moleculin Biotech stock price for the last 52 weeks is 3.53.
An investor who bought $1,000 worth of Moleculin Biotech stock at the IPO in 2016 would have $-998 today, roughly -1 times their original investment - a -50.02% compound annual growth rate over 9 years.
The all-time high Moleculin Biotech stock closing price was 801.00 on June 03, 2016.
The Moleculin Biotech 52-week high stock price is 10.34, which is 638.6% above the current share price.
The Moleculin Biotech 52-week low stock price is 0.40, which is 71.4% below the current share price.
The average Moleculin Biotech stock price for the last 52 weeks is 3.53.